𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies

✍ Scribed by Galit Eliyahu; Tamar Kreizman; Hadassa Degani

Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
661 KB
Volume
120
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The discovery of metabolic and molecular markers that help improving the detection and diagnosis of breast cancer is an important goal to be achieved. A high composite‐choline signal in magnetic resonance spectra of breast lesions has been demonstrated to improve the accuracy of breast cancer diagnosis. In the present study we revealed the principal molecular and biochemical steps associated with the induction of choline metabolism and phosphocholine accumulation in human breast cancer cell‐lines in comparison with normal human mammary epithelial cells. We found upregulation of the expression levels of specific choline transporters: organic cation transporter‐2 and choline high affinity transporter‐1, as well as of the enzyme choline kinase α in the cancerous cells in comparison with that in the normal mammary epithelial cells. The expression levels of choline transporter like‐1, organic cation transporter‐1 and choline kinase β were similar in normal and cancerous cells. We further showed that choline transport rates and choline kinase activity indeed increased by several fold in the cancer cells leading to the elevation of phosphocholine. The results strongly suggest that phosphocholine can serve as a biomarker of breast cancer reflecting upregulation of specific choline transporters and choline kinase genes. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

HER-2: A biomarker at the crossroads of
HER-2: A biomarker at the crossroads of breast cancer immunotherapy and molecular medicine
✍ Serenella M. Pupa; Elda Tagliabue; Sylvie Ménard; Andrea Anichini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

## Abstract The oncoprotein encoded by the HER‐2 oncogene is a member of the HER family of receptor tyrosine kinases and is actually the first successfully exploited target molecule in new biomolecular therapies of solid tumors. The association of HER‐2 overexpression with human tumors, its extrace

GSTP1 CpG island hypermethylation as a m
GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer
✍ Masashi Nakayama; Mark L. Gonzalgo; Srinivasan Yegnasubramanian; Xiaohui Lin; An 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

## Abstract Somatic hypermethylation of CpG island sequences at __GSTP1__, the gene encoding the π‐class glutathione S‐transferase, appears to be characteristic of human prostatic carcinogenesis. To consider the potential utility of this epigenetic alteration as a biomarker for prostate cancer, we

A biochemical approach to the staging of
A biochemical approach to the staging of human breast cancer
✍ R. C. Coombes; T. J. Powles; J. C. Gazet; H. T. Ford; A. G. Nash; J. P. Sloane; 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Ten biochemical parameters, each of which has been individually advocated in the past as a tumor-index substance for breast cancer, were measured in 5 1 patients with breast disease, 42 of whom had active breast cancer. All patients with overt metastatic breast cancer had abnormalities of at least t